Large-scale phase 3 trial shows significant reduction in cardiovascular and kidney disease risk First public reveal of results from large-scale, Sanofi-led global phase 3 trial for efpeglenatide Hanmi aims to achieve new innovations with biologic SEOUL, South Korea, June 29, 2021 /PRNewswire/ — Hanmi Pharmaceutical (hereinafter Hanmi) recently announced that its new, […]